UPDATED May 28, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SSB | US$77.37 | -2.7% | 19.3% | US$5.9b | US$92.41 | PB1.1x | E25.8% | 2.7% | Banks | ||
SIGI | US$95.00 | -1.8% | -4.8% | US$5.9b | US$106.43 | PE16.7x | E23.1% | 1.5% | Insurance | ||
USCB | US$12.09 | 1.4% | 20.9% | US$235.9m | US$13.50 | PB1.2x | E25.3% | 1.7% | Banks | ||
HNVR | US$16.54 | -0.2% | -7.5% | US$119.6m | US$18.50 | PB0.6x | E20.9% | 2.4% | Banks | ||
HBIO | US$3.18 | -2.8% | -43.1% | US$137.2m | US$7.00 | PS1.3x | E106.7% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$124.36 | 7.4% | 59.4% | US$23.2b | US$148.02 | PE11.8x | E18.2% | 6.2% | Diversified Financials | ||
HQY | US$79.19 | -0.2% | 43.3% | US$6.9b | US$100.00 | PE123.7x | E41.4% | n/a | Healthcare | ||
TLRY | US$1.82 | -4.7% | -0.5% | US$1.5b | US$2.37 | PS2x | E86.8% | n/a | Pharmaceuticals & Biotech | ||
ENFN | US$9.62 | 4.3% | 24.5% | US$1.2b | US$9.82 | PE440.1x | E99.0% | n/a | Software | ||
MRNA | US$153.20 | 6.6% | 18.9% | US$63.9b | US$138.51 | PS11.4x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
CRC | US$47.89 | -0.04% | 25.4% | US$3.2b | US$63.00 | PE13x | E33.8% | 2.6% | Energy | ||
CARE | US$12.68 | -6.4% | -11.5% | US$297.6m | US$15.00 | PB0.8x | E32.8% | 0% | Banks | ||
ODD | US$36.33 | -4.3% | n/a | US$2.1b | US$52.29 | PE28.7x | E18.6% | n/a | Household | ||
AUB | US$31.95 | -5.3% | 22.7% | US$2.9b | US$38.40 | PB1.1x | E23.5% | 4.0% | Banks | ||
APP | US$83.23 | -0.9% | 243.5% | US$27.0b | US$93.24 | PE46.1x | E24.7% | n/a | Software | ||
PWFL | US$5.41 | -1.6% | 71.7% | US$564.8m | US$8.43 | PS4.3x | E117.6% | n/a | Tech | ||
SMAR | US$39.29 | -5.7% | -18.3% | US$5.5b | US$49.26 | PS5.6x | E51.0% | n/a | Software | ||
LYV | US$94.89 | -7.0% | 18.3% | US$22.1b | US$118.64 | PE86.5x | E27.9% | n/a | Media | ||
RPD | US$37.70 | -1.0% | -20.2% | US$2.4b | US$49.48 | PS2.9x | E75.9% | n/a | Software | ||
GLBE | US$30.58 | 1.8% | -9.0% | US$4.9b | US$43.50 | PS8.5x | E92.6% | n/a | Retail | ||
ASB | US$21.02 | -3.4% | 36.4% | US$3.1b | US$23.80 | PB0.8x | E42.3% | 4.2% | Banks | ||
LPRO | US$6.26 | -0.8% | -38.1% | US$774.6m | US$7.67 | PE51x | E42.1% | n/a | Diversified Financials | ||
IBTA | US$105.84 | 0.1% | n/a | US$3.2b | US$120.86 | PE84.3x | E48.9% | n/a | Media | ||
SACH | US$2.89 | -8.8% | -7.1% | US$145.2m | US$4.33 | PE11.9x | E25.9% | 15.2% | Diversified Financials |